• Clinical class: anticonvulsant
• Action: gamma-aminobutyric acid transaminase (GABA-T) inhibitor
• CSA schedule: none
• DEA number: none

U.S. Preparations:

• Sabril^® tablets (Lundbeck) FDA approved:
  8.21.2009: treatment of refractory complex partial seizures in adults
  US prescribing information
• Sabril^® oral solution (Lundbeck) FDA approved:
  8.21.2009: treatment of infantile spasms
  US prescribing information

Preparations Outside U.S.:

• Sabrilex

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2010 BehaveNet®